Cecelia Perkins

Efficacy and safety of midostaurin in patients with advanced systemic mastocytosis: 10-year median follow-up of a phase II trial

Daniel J. DeAngelo, Tracy I. George, Andrea Linder et al. · Leukemia · 2017 · 136 citations

Phase Ii Trial, Advanced Systemic Mastocytosis, Systemic Treatment +5

International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study

Wolfgang R. Sperr, Michael Kundi, Iván Álvarez‐Twöse et al. · The Lancet Haematology · 2019 · 135 citations · Full text

Mast Cell Disorder, Clinical Epidemiology, Diagnosis +3

MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis

Mohamad Jawhar, Juliana Schwaab, Iván Álvarez‐Twöse et al. · Journal of Clinical Oncology · 2019 · 121 citations · Full text

Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis

Lukas Ronner, Nikolai A. Podoltsev, Jason Gotlib et al. · Blood · 2020 · 76 citations · Full text

Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification

Jakub Trizuljak, Wolfgang R. Sperr, Lucie Nekvindová et al. · Allergy · 2020 · 73 citations · Full text